Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Medical College of Wisconsin
University of Colorado, Denver
Seagen Inc.
Merck Sharp & Dohme LLC
University of Kentucky
Hospices Civils de Lyon
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan Rogel Cancer Center
Eastern Cooperative Oncology Group
Dana-Farber Cancer Institute
R-Pharm
University of Texas Southwestern Medical Center
University of Leipzig
University of California, San Diego
Mayo Clinic
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Icahn School of Medicine at Mount Sinai
Heidelberg University
University of California, San Diego
University of Michigan Rogel Cancer Center
CHU de Reims
Xinqiao Hospital of Chongqing
Hôpital de la Croix-Rousse
Radiation Therapy Oncology Group
University of Pittsburgh
Maastricht University Medical Center
Centre Henri Becquerel
Centre Henri Becquerel
Pharmassist Ltd
Jacobio Pharmaceuticals Co., Ltd.
Kura Oncology, Inc.